欢迎访问《标记免疫分析与临床》官方网站!
临床研究

流式细胞术在我院急性白血病免疫分型中的应用

  • 杨川艺,倪萍,涂文瑞
展开
  • 福建中医药大学附属三明市中西医结合医院,福建三明 365001

网络出版日期: 2013-12-14

Application of Flow Cytometry in Immune from the Classification of Acute Leukemia

  • YANG Chuan-yi,NI Ping,TU Wen-rui
Expand
  • Fujian University of Traditional Chinese Medicine Affiliated Sanming City Hospital of Integrated Traditional and Western Medicine, Sanming 365001, China

Online published: 2013-12-14

摘要

摘要 目的  探讨本实验室所用13种单抗对白血病免疫分型的应用价值。方法  应用流式细胞术(FCM)使用13种单抗对99例急性白血病进行免疫分型,与形态学分型相比较。结果 使用13种单抗从99例急性白血病中分出髓系白血病(AML59例、淋系白血病(ALL27例、混合型(MAL5例、未分化型(AUL2例,诊断率达93.9%93/99)。AML中各抗原表达情况:CD13> CD33> CD14CD7> CD2CD19> CD10> CD5> CD20,其中多表达CD13CD33ALL中各抗原表达情况:CD19> CD13> CD10> CD20> CD33> CD5> CD7>CD2CD14,其中CD10CD13CD19CD20表达率较高。免疫分型与形态学分型结果相比较,AML二者的吻合率为90.5%57/63)、ALL二者的吻合率为76.5%26/34);其中1M0免疫分型为B/M混合、1M1免疫分型为T/M混合、1M2a免疫分型为T/M混合、1L1免疫分型为B/M混合、1L2免疫分型为T/B混合、1L2免疫分型为Ly+-AML2L2免疫分型为AUL1例形态学为浆细胞白血病的免疫分型为AML1例淋单混合型白血病CD7CD13CD14 阳性。结论 白血病细胞、免疫分型各具特征,形态学相同的白血病免疫分型未必相同,形态学不同的白血病免疫分型未必不同;本实验室所选单抗组合基本能满足白血病的免疫分型,对于一些混合型和未分化型白血病的诊断亦能明确。

本文引用格式

杨川艺,倪萍,涂文瑞 . 流式细胞术在我院急性白血病免疫分型中的应用[J]. 标记免疫分析与临床, 2013 , 20(6) : 414 -417 . DOI: 10.11748/bjmy.issn.1006-1703.2013.06.016

Abstract

Abstract: Objective To explore the application value of the 13 kinds of monoclonal antibody for leukemia immunophenotyping. Methods The immunophenotye of 99 cases of acute leukemia were determined by flow cytometry (FCM) with 13 monoclonal antibodies, and compared with morphological classification results. Results The results showed that 59 cases of acute marrow leukemia (AML), 27 cases of acute lymphocyte leukemia (ALL),5 cases of mixed acute leukemia (MAL) and 2 cases of acute undifferentiated leukemia (AUL) were differentiated by using these monoclonal antibodies. The diagnosis rate was 93.9% (93/99). The expression of lineage antigens in AML was CD13> CD33> CD14, CD7> CD2, CD19> CD10> CD5> CD2, most express CD13 and CD33the expression of lineage antigens in ALL was CD19> CD13> CD10> CD20> CD33> CD5> CD7>CD2, CD14, most express CD10, CD13, CD19 and CD20. The coincidence rate with morphology results was 90.5% for AML and 76.5% for ALL. Among these, one M0 was B lymphocyte leukemia and marrow leukemia mixed, one M1 was T lymphocyte leukemia and marrow leukemia mixed, one M2a was T lymphocyte leukemia and marrow leukemia mixed, one L1 was B lymphocyte leukemia and marrow leukemia mixed, one L2 was T and B lymphocyte leukemia mixed, one L2 was Ly+-AML, two L2 was AUL, one lymphocyte-monocyte mixing expressing CD7, CD13 and CD14. Conclusion Each Immunophenotype of AL has own character, and might need multifold monoclonal antibody to analysis. Although AL has the same morphology type, its Immunophenotype might not same, and vice versa. The combination of monoclonal antibody which our laboratory choosed are sufficient to analysis Immunophenotype of AL on the whole, and also can diagnose some mixed acute leukemia and acute undifferentiated leukemia.
文章导航

/